Non-Current Assets

Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)

Merck & Co. Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) increased by 80.0% to $2.70B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 80.0%, from $1.50B to $2.70B. Over 5 years (FY 2020 to FY 2025), Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) shows an upward trend with a 17.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ4 2025Feb 24, 2026

How to read this metric

Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.

Detailed definition

This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...

Peer comparison

Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.

Metric ID: finite_lived_intangible_assets_amortization_year_1

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$1.40B$1.30B$1.10B$1.50B$2.70B
QoQ Change-7.1%-15.4%+36.4%+80.0%
YoY Change-7.1%-15.4%+36.4%+80.0%
Range$1.10B$2.70B
CAGR+92.9%
Avg YoY Growth+23.5%
Median YoY Growth+14.6%
Current Streak2 quarters growth

Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) at Other Companies

Frequently Asked Questions

What is Merck & Co.'s finite-lived intangible assets - expected amortization expense (year one)?
Merck & Co. (MRK) reported finite-lived intangible assets - expected amortization expense (year one) of $2.70B in Q4 2025.
How has Merck & Co.'s finite-lived intangible assets - expected amortization expense (year one) changed year-over-year?
Merck & Co.'s finite-lived intangible assets - expected amortization expense (year one) increased by 80.0% year-over-year, from $1.50B to $2.70B.
What is the long-term trend for Merck & Co.'s finite-lived intangible assets - expected amortization expense (year one)?
Over 5 years (2020 to 2025), Merck & Co.'s finite-lived intangible assets - expected amortization expense (year one) has grown at a 17.6% compound annual growth rate (CAGR), from $1.20B to $2.70B.
What does finite-lived intangible assets - expected amortization expense (year one) mean?
The expected non-cash expense for amortizing intangible assets over the next twelve months.